Infectious Disease

PSI is a leading full-service CRO with 800+ staff in Europe (Eastern, Central, Western), the USA and Latin America.

PSI is known and respected for consistently securing fast patient enrollment into clinical trials of all sizes and levels of complexity, across a broad range of indications.

PSI has successfully performed Phase II/III studies in the following infectious disease indications:

Acute bronchitis
Candidiasis
- Oropharyngeal
- Esophageal
- Invasive
ENT infections
Hepatitis
- HAV
- HBV
- HCV
Herpes simplex
Herpes zoster
HIV/AIDS
HIV-associated infections

Influenza
Meningitis
Otitis media
Peritonitis and IAI
PID
Pneumonia
- CAP
- HAP
Sepsis
Skin infections
Tuberculosis
UTI
Vaccine augmentation

PSI has developed a database of 1,700+ infectious disease sites, grouped by indication, as listed below:

Infectious Disease Indication	# Sites
Acute bronchitis	132
Candidiasis, esophageal & oropharyngeal	17
Candidiasis, invasive	40
ENT infections	87
Hepatitis (HAV, HBV, HCV)	80
Herpes simplex	63
Herpes zoster	36
HIV/AIDS	19
Influenza	307
Meningitis	39
Otitis media	61
Peritonitis and IAI	135
PID	137
Pneumonia (CAP, HAP)	117
Sepsis	77
Skin infections	100
Tuberculosis	37
UTI	118
Vaccine augmentation	112
	1,714

PSI employs physicians as full-time monitors and project managers, most of whom are board certified specialists, including internists, infectious disease specialists, pulmonologists, dermatologists, ENT-specialists, gynecologists, surgeons, and urologists.